High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer

Cancer Research

Volumn 61, Issue 11, 2001, Pages 4514-4519

  Simon, Ronald ^a   Richter, Jan ^a   Wagner, Urs ^a   Fijan, André ^a   Bruderer, James ^a   Schmid, Ulrico ^b   Ackermann, Daniel ^b   Maurer, Robert ^c   Alund, Göran ^c   Knönagel, Hartmut ^d   Rist, Marcus ^e   Wilber, Kim ^f   Anabitarte, Manuel ^g   Hering, Franz ^g   Hardmeier, Thomas ^h   Schönenberger, Andreas ^h   Flury, Renata ⁱ   Jäger, Peter ⁱ   Fehr, Jean Luc ^j   Schraml, Peter ^a   Moch, Holger ^a   Mihatsch, Michael J ^a   Gasser, Thomas ^k   Sauter, Guido ^a   more..

^a UNIVERSITY OF BASEL   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

^d Spital Limmattal   (Switzerland)

^e Clara Hospital   (Switzerland)

^f ABBOTT LABORATORIES   (United States)

^g Cantonal Hospital Baden   (Switzerland)

^h Kantonsspital Muensterlingen   (Switzerland)

ⁱ CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^j Hospitals Schaffhausen   (Switzerland)

^k Kantonsspital Liestal   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER SURVIVAL; CHROMOSOMAL LOCALIZATION; CHROMOSOME 3P; CHROMOSOME 8P; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DELETION MUTANT; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROANALYSIS; PRIORITY JOURNAL; TUMOR GROWTH;

CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 0035361601     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chromosomal imbalances in small cell carcinomas of the urinary bladder
2. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization
3. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization
4. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer
5. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization
6. Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer
7. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
8. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization
9. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer
10. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa)
11. Raf-1: A kinase currently without a cause but not lacking in effects
12. Fibroblast growth factor receptors (FGFRs) and their roles in limb development
13. DNA alterations at proto-oncogene loci and their clinical significance in operable non-small cell lung cancer
14. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification
15. Relating genotype and phenotype in breast cancer: An analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations
16. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues
17. Tissue microarrays for high-throughput molecular profiling of tumor specimens
18. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer
19. Histological typing of urinary bladder tumors
20. Tissue microarrays for gene amplification surveys in many different tumor types
21. Nonparametric estimation from incomplete observations
22. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
23. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets
24. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck
25. Expression of cyclin D1 and EMS1 in bladder tumors: Relationship with chromosome 11q13 amplification
26. Identification of novel regions of altered DNA copy number in small cell lung tumors
27. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
28. Allelotype and replication error phenotype of small cell lung carcinoma
29. Allelotype of human bladder cancer
30. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer
31. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms
32. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer